Daojin Yu

Prof. Daojin Yu


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
LALiaqat Ali
Liaqat Ali
MUMohsan Ullah
Mohsan Ullah
YAYasir Arafat
Yasir Arafat
MAMuhammad Ajmal
Muhammad Ajmal
JCJi-Long Chen
Ji-Long Chen
DYDaojin Yu
Daojin Yu
Quorum-sensing systems control major virulence determinants in Enterococcus faecalis, which causes nosocomial infections. The E. faecalis quorum-sensing systems include several virulence factors that are regulated by the cytolysin operon, which encodes the cytolysin toxin. In addition, the E. faecalis Fsr regulator system controls the expression of gelatinase, serine protease, and enterocin O16. The cytolysin and Fsr virulence factor systems are linked to enterococcal diseases that affect the health of humans and other host models. Therefore, there is substantial interest in understanding and targeting these regulatory pathways to develop novel therapies for enterococcal infection control. Quorum-sensing inhibitors could be potential therapeutic agents for attenuating the pathogenic effects of E. faecalis. Here, we discuss the regulation of cytolysin, the LuxS system, and the Fsr system, their role in E. faecalis-mediated infections, and possible therapeutic approaches to prevent E. faecalis infection.

13 November 2019 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
TSTong Sun
Tong Sun
XLXiao-Dong Li
Xiao-Dong Li
JHJuan Hong
Juan Hong
CLCan Liu
Can Liu
XZXin-Luo Zhang
Xin-Luo Zhang
DYDaojin Yu
Daojin Yu
The quorum sensing (QS) system controls bacterial biofilm formation, which is highly related to the virulence and resistance of pathogens. In the present study, the effect of two traditional Chinese medicine (TCM) monomers, berberine and matrine, on biofilm formation and QS-related gene expression of antimicrobial-resistant (AMR) Escherichia coli strains was investigated by laser scanning confocal microscopy (LSCM) observation and real-time PCR. The results indicated a roughly positive relationship between biofilm formation ability and antimicrobial resistance. LSCM observation showed that berberine and matrine inhibited biofilm formation of AMR E. coli strains at 1/2 minimal inhibitory concentration (MIC) (1/2 MIC berberine at OD630: 0.1020; 1/2 MIC matrine: OD630: 0.1045); furthermore, abnormal cell morphology such as rounded and elongated cells was also observed. This finding was consistent with the downregulation of QS-related genes: luxS, pfS, sdiA, hflX, motA, and fliA. At 1/2 MIC and 1/4 MIC concentrations of berberine, a significant downregulation of luxS, pfS, hflX, ftsQ, and ftsE was observed. The results indicate that berberine and matrine can inhibit biofilm formation by inhibiting the QS system and that berberine is more effective than matrine.

1 August 2009 in Chemosphere
Verified
Journal Article
Closed access
DYDaojin Yu
Daojin Yu
XYXiuli Yi
Xiuli Yi
YMYufang Ma
Yufang Ma
BYBing Yin
Bing Yin
HZHonglin Zhuo
Honglin Zhuo
YHYifan Huang
Yifan Huang

1 December 2016 in Journal of Global Antimicrobial Resistance
Verified
Journal Article
Closed access
LALiaqat Ali
Liaqat Ali
YWYan-Qiu Wang
Yan-Qiu Wang
JZJie Zhang
Jie Zhang
MAMuhammad Ajmal
Muhammad Ajmal
ZXZhengrun Xiao
Zhengrun Xiao
DYDaojin Yu
Daojin Yu

14 December 2019 in Microbial Ecology
Verified
Journal Article
Closed access
PDF file
XLXiao-Dong Li
Xiao-Dong Li
YCYu-Hong Chen
Yu-Hong Chen
CLCan Liu
Can Liu
JHJuan Hong
Juan Hong
HDHui Deng
Hui Deng
DYDaojin Yu
Daojin Yu

30 April 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
ZXZhang Xiaorui
Zhang Xiaorui
QKQi-hong Kuang
Qi-hong Kuang
JXJianguang Xu
Jianguang Xu
QLQing Lin
Qing Lin
HCHaoming Chi
Haoming Chi
DYDaojin Yu
Daojin Yu
Mesenchymal stem cells (MSCs) are multipotent stromal cells with the ability to self-renew and multi-directional differentiation potential. Exogenously administered MSCs can migrate to damaged tissue sites and participate in the repair of damaged tissues. A large number of pre-clinical studies and clinical trials have demonstrated that MSCs have the potential to treat the abnormalities of congenital nervous system and neurodegenerative diseases. Therefore, MSCs hold great promise in the treatment of neurological diseases. Here, we summarize and highlight current progress in the understanding of the underlying mechanisms and strategies of MSC application in neurological diseases.